Chemometec — Februar 2023
-
Aktietilbagekøb i den nuværende situation , vil, efter min mening, ikke ændre noget. 1) Eksisterende kunder køber meget lidt af eksisterende produkter. Nyt produkt, Cm40, endnu ikke klar - og har kunderne råd til den? Intet, som i overhovedet intet, nyt omkring ny CEO. Ser, alt ialt, ikke voldsomt positivt ud. Tror, vi må håbe på kaninen, der springer op af hatten
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind